Gabelli Healthcare & WellnessRx Trust
The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund … Read more
Gabelli Healthcare & WellnessRx Trust (GRX) - Net Assets
Latest net assets as of June 2025: $163.65 Million USD
Based on the latest financial reports, Gabelli Healthcare & WellnessRx Trust (GRX) has net assets worth $163.65 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($197.45 Million) and total liabilities ($33.80 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $163.65 Million |
| % of Total Assets | 82.88% |
| Annual Growth Rate | 5.56% |
| 5-Year Change | -29.45% |
| 10-Year Change | N/A |
| Growth Volatility | 150.82 |
Gabelli Healthcare & WellnessRx Trust - Net Assets Trend (2007–2024)
This chart illustrates how Gabelli Healthcare & WellnessRx Trust's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Gabelli Healthcare & WellnessRx Trust (2007–2024)
The table below shows the annual net assets of Gabelli Healthcare & WellnessRx Trust from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $170.86 Million | -7.55% |
| 2023-12-31 | $184.81 Million | -9.70% |
| 2022-12-31 | $204.65 Million | -22.47% |
| 2021-12-31 | $263.95 Million | +8.99% |
| 2020-12-31 | $242.17 Million | -20.98% |
| 2019-12-31 | $306.46 Million | +12.82% |
| 2018-12-31 | $271.65 Million | -9.35% |
| 2017-12-31 | $299.68 Million | +469.50% |
| 2008-12-31 | $52.62 Million | -22.69% |
| 2007-12-31 | $68.07 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Gabelli Healthcare & WellnessRx Trust's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 22153.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $60.85 Million | 35.61% |
| Common Stock | $110.02 Million | 64.39% |
| Total Equity | $170.86 Million | 100.00% |
Gabelli Healthcare & WellnessRx Trust Competitors by Market Cap
The table below lists competitors of Gabelli Healthcare & WellnessRx Trust ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Brpr Corporate Offices Fundo De Investimento Imobiliario
SA:BROF11
|
$92.56K |
|
Business Development Corp Of America
PINK:BDVC
|
$92.61K |
|
Silver Spruce Resources Inc
PINK:SSEBF
|
$92.67K |
|
7610
TW:7610
|
$92.71K |
|
Cranstown Capital Corp
V:CRAN-P
|
$92.49K |
|
Abacus Global Management, Inc.
NASDAQ:ABX
|
$92.43K |
|
250030
KO:250030
|
$92.42K |
|
Genians Inc.
KO:263860
|
$92.42K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Gabelli Healthcare & WellnessRx Trust's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 184,809,973 to 170,861,787, a change of -13,948,186 (-7.5%).
- Net loss of 285,000 reduced equity.
- Dividend payments of 9,366,197 reduced retained earnings.
- Share repurchases of 4,469,572 reduced equity.
- New share issuances of 10,350,000 increased equity.
- Other factors decreased equity by 10,177,417.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-285.00K | -0.17% |
| Dividends Paid | $9.37 Million | -5.48% |
| Share Repurchases | $4.47 Million | -2.62% |
| Share Issuances | $10.35 Million | +6.06% |
| Other Changes | $-10.18 Million | -5.96% |
| Total Change | $- | -7.55% |
Book Value vs Market Value Analysis
This analysis compares Gabelli Healthcare & WellnessRx Trust's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.84x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.54x to 0.84x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $17.26 | $9.28 | x |
| 2018-12-31 | $14.54 | $9.28 | x |
| 2019-12-31 | $16.64 | $9.28 | x |
| 2020-12-31 | $13.81 | $9.28 | x |
| 2021-12-31 | $15.32 | $9.28 | x |
| 2022-12-31 | $12.01 | $9.28 | x |
| 2023-12-31 | $11.58 | $9.28 | x |
| 2024-12-31 | $11.01 | $9.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Gabelli Healthcare & WellnessRx Trust utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.17%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -8.74%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 1.32x
- Recent ROE (-0.17%) is below the historical average (0.27%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 1.02% | 45.74% | 0.02x | 1.03x | $-6.11 Million |
| 2008 | -28.55% | -1672.43% | 0.02x | 1.02x | $-20.29 Million |
| 2017 | 10.57% | 97.50% | 0.11x | 1.00x | $1.72 Million |
| 2018 | -0.84% | 0.00% | -0.01x | 1.00x | $-29.44 Million |
| 2019 | 17.38% | 98.88% | 0.18x | 1.00x | $22.58 Million |
| 2020 | 9.99% | 96.71% | 0.09x | 1.18x | $-35.38K |
| 2021 | 16.19% | 98.27% | 0.12x | 1.33x | $16.34 Million |
| 2022 | -23.18% | 0.00% | -0.19x | 1.22x | $-67.91 Million |
| 2023 | 0.23% | 10.53% | 0.02x | 1.29x | $-18.06 Million |
| 2024 | -0.17% | -8.74% | 0.01x | 1.32x | $-17.37 Million |
Industry Comparison
This section compares Gabelli Healthcare & WellnessRx Trust's net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $310,488,743
- Average return on equity (ROE) among peers: -23.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Gabelli Healthcare & WellnessRx Trust (GRX) | $163.65 Million | 1.02% | 0.21x | $92.50K |
| Aberdeen International Inc (AABVF) | $136.31 Million | 25.56% | 0.23x | $2.78 Million |
| Acadian Asset Management Inc (AAMI) | $-17.60 Million | 0.00% | 0.00x | $1.39 Billion |
| AllianceBernstein Holding L.P. (AB) | $402.30 Million | 32.07% | 0.95x | $3.43 Billion |
| VIVO Cannabis Inc (ABCCF) | $164.13 Million | 16.36% | 0.09x | $148.26 Million |
| Associated Capital Group Inc (AC) | $502.13 Million | 5.33% | 0.17x | $42.54 Million |
| Adrian Resources Ltd (ADLRF) | $605.01 Million | 3.35% | 0.58x | $609.82 Million |
| Abrdn Emerging Markets Equity Income Fund Inc (AEF) | $85.10 Million | -65.65% | 0.01x | $77.20K |
| AGF Management Limited (AGFMF) | $1.12 Billion | 10.14% | 3.56x | $298.43 Million |
| Agronomics Limited (AGNMF) | $100.03 Million | 1.02% | 0.02x | $57.14 Million |
| AgriFORCE Growing Systems Ltd (AGRI) | $6.11 Million | -266.31% | 0.76x | $2.71 Million |